India's pharmaceutical exports reached an unprecedented $30.47 billion in FY25, reflecting a 9.4% year-on-year growth. This achievement underscores the country's expanding role as a global leader in generic medicine supply.

Key Points:

• India’s pharmaceutical exports totaled $30.47 billion in FY25, up from $27.85 billion in FY24, marking the first time exports have crossed the $30 billion threshold.
• March 2025 witnessed a significant 31.2% year-on-year increase in pharma exports, amounting to $3.68 billion, the highest monthly surge of the fiscal year.
• The United States remained the largest importer, accounting for over one-third of India's pharma exports, with a 14.29% increase to $8.95 billion. Other key markets included the UK, Brazil, France, and South Africa.
• India continues to solidify its position as the world's largest supplier of generic medicines, contributing significantly to global healthcare needs.
• Industry reports project continued growth, with expectations of the pharmaceutical market reaching $130 billion by 2030, driven by increased demand and innovation.